Stay updated with breaking news from Nasdaq Acrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $5.00 target price on shares of AcelRx Pharmaceuticals in a research report […]
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other analysts have also recently commented on ACRX. Alliance Global Partners began coverage on AcelRx Pharmaceuticals in a report on Monday, October […]
StockNews.com started coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently commented on ACRX. HC Wainwright reaffirmed a buy rating and set a $5.00 price objective on shares […]
StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a report issued on Saturday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Several other analysts have also issued reports on the stock. HC Wainwright restated a buy rating and issued a $5.00 price objective on shares of […]
StockNews.com began coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Several other brokerages also recently issued reports on ACRX. Alliance Global Partners started coverage on shares of AcelRx Pharmaceuticals in a report on […]